Kenneth Research recently added a report on Protein Sequencing Industry Market in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth opportunities and growth drivers that are associated with the growth of the market. The report additionally shares critical insights on the COVID-19 impacts on the Protein Sequencing Industry Market along with the compound growth rate (CAGR) of the market for a projected period between 2022 and 2031. The report also includes analysis of the market by utilizing different analytical tools, such as PESTEL analysis and Porter’s five forces analysis. These tools also provide an in-depth analysis on the micro and macro-environmental factors that are associated with the growth of the market during the forecast period.
In Q4 2021, U.S. current-account deficit widened stood at $224.8 billion. However, in Q1 22, CAD rose by 29.6%, reached to $291.4 billion, adding $66.6 billion to the gap. Export of good and services increased by $25.7 billion to reach $1.03 trillion in the first quarter of 2022. However, country’s goods and services deficit was $79.6 billion in June, down $5.3 billion from $84.9 billion in May, revised- reflecting some sight of relief. On the other hand, annual inflation rate in the country hit 8.5%. Energy CPI surged by 32.9% in July 2022, inflating the cost of logistic and signs to disrupt supply chain whilst electricity cost upsurged by 15.2%, highest since Feb 2006. Apart from that, In July 2022, existing US home sales declined 5.9% to 4.81 million (seasonally adjusted annual rate), the lowest since May of 2020 and below market expectations of 4.89 million. As mortgage rate touches highest at 6%, sales for houses declined for a sixth consecutive month. Global energy crises to remain at focal point impacting the economic activity in the U.S, pushing consumers to spend less on the products and services and save more.
On the other hand, the worst is expected to be seen in the European countries, especially during 2022 winters. The energy and gas crises has already started grappling the region, wherein many Western European countries including Germany is looking for coal fired solutions to tackle the gas supply shortage created by Russian-Ukraine conflict.
Amidst global concerns, market players have started looking for safe investments by holding on to the new technology and product launches. Factors like currency translation, disruption in global supply chain, Anti-China sentiments brewing across the globe, slowdown in Chinese economy, inflated products prices, USD getting stronger every week, decreasing purchasing power and strict measures taken by central banks/institutions across the world to ensure less spending and more saving, could hit the demand for the product and service badly in near future.
Healthcare Companies and Private Service Providers to have a minimal damage Caused by Inflation:
As US govt. remains committed to quality by spending more in the Medicaid and Medicare programs, incentives by govt. to medical devices, pharma companies and biotech to benefit the market players in short and long term goals. In 2021, U.S. spent $12,318/person on healthcare- highest amongst all OECD countries followed by Germany at $7,383. The federal government commitment towards healthcare systems to enable market players expanding their revenues and mitigating the risk posed by the inflation.
Download Sample PDF of this Report: – https://www.kennethresearch.com/sample-request-10151814
“The Global Protein Sequencing market was valued at ~USD 7 billion in 2021 and is likely to expand at a CAGR of ~8% from 2022 to 2030. Proteins are a novel sequencing method for the determination and analysis of amino acid sequences by mass. Spectroscopy.
This process provides researchers with information about protein structure. Protein sequencing has proven to be a powerful proteomics technique for many applications. One notable application area is targeted drug discovery. Quantify protein sequencing, specifically Edman degradation and mass spectrometry, using a combination of various computational and experimental methods. Many biotechnology and pharmaceutical companies have invested heavily in the use of protein sequencing in pharmaceutical manufacturing.
In addition, breakthrough advances in high-performance technology have enabled rapid parallel sequencing of proteins. High-resolution sequencing of small amounts of proteins can help elucidate gene products and intracellular structures. Growing interest in biotechnology and targeted drug development activities of pharmaceutical companies in various growth and development sectors has become an important driver for protein sequencing in the market.
Recent development of novel peptide sequencing and analysis methods using neural networks has opened up new avenues for the market. Technological advances in mass spectrometry are a good example. Additionally, advances in nanosensors and single-molecule fluorescence devices have made it possible to detect specific peptide residues. In many developed and developing countries, funding for protein research is an important factor in advancing the market. The increasing demand for protein biomarkers in pharmaceutical manufacturing processes is a major trend driving the rapid expansion of the protein sequencing market. However, the adsorption of protein sequencing is limited by the high cost of infrastructure and equipment such as mass spectrometers.
Moreover, monitoring and localization of peptide sites is a major technical barrier to the development of next-generation methods for sequencing proteins. The adoption of protein sequencing technology to identify novel peptides from human antibodies and antigens is also driving the protein sequencing market.
Additionally, some regions of the world lack adequate technology and laboratory infrastructure to fully exploit the market potential. However, advances in technology to identify isotopic residues in protein sequences are expected to open up a wide range of potential approaches in the global protein sequence market.
Access Full Report here – https://www.kennethresearch.com/report-details/protein-sequencing-industry-market/10151814
Global Protein Sequencing Market Segmentation:
The Protein Sequencing market is segmented on the basis of product, service, technology, application, end user, and region. On the basis of products and services, the market is segmented into reagents, consumables, tools, analytical products, and protein sequencing services. In addition, devices are further divided into Edman annihilation and mass spectrometers.
Based on this technology, the market is divided into mass spectrometry and Edman decomposition. Based on application, the market is split into academic research, biomedical research, and biotechnology. At the regional level, we analyzed the North America, Europe, Asia Pacific and Lamia markets.
Edman degradation accounts for 60% of the overall market share in 2020 and is expected to grow significantly in the near future owing to the widespread use of protein sequencing. Edman digestion is also a major method of protein sequencing. This involves continuous hydrolysis of the peptide to phenyl isothiocyanate, starting at the N-terminus of the polypeptide. However, the mass spectrometry market is expected to grow faster during the forecast period. This is due to the increasing use of mass spectrometry techniques for fast and rapid long-chain sequencing of proteins.
Based on scope assessment protein sequencing market analysis:
the biopharmaceutical industry using this program is dominated the protein sequencing market in 2020 and maintain its dominance during the forecast period. This has contributed to the increased use of protein sequences in the development of new biological therapies. Furthermore, classification of biomolecules into constituent peptides by proteolysis is essential for full coverage of biomedical molecular sequences.
North America is a major revenue source for the global protein sequencing market owing to advances in sequencing system technology and an increase in protein sequencing programs in the region. Europe has the second largest market share in the world. Bioinformatics Solutions Inc recognizes the growing demand for protein sequencing and key drivers for predicting the growth of the European protein sequencing market. Charles River Laboratories and Agilent Technologies, Inc., Proteome Factory and Rapid Novor Inc. And in-depth competitive analysis and analysis of key market players such as Selvita, SGS, Shimadzu, Thermo Fisher Scientific Inc. are some of the key players. In the global sequencing of proteins market highlighted in this report.
Key Advantages of Protein Sequence Market:
Market Share Listing and Protein Sequence Analysis Fundamental advancements in the Protein Sequence Analysis industry are based on a comprehensive analysis of the growth strategies of key players to understand the competitive landscape in the global market.
This study provides key factors, limitations, opportunities and market impact from the analysis along with detailed analysis of market trends, visible investments and global trends in Protein Sequences from 2022-2030
The purpose of the analysis is analysis of the five forces. Efficiency of buyers and suppliers in their sector. It is based on forecasts of the global Protein Sequences market from 2022-2030 and ascertains the market potential, complete competitive analysis, and profiles of key market players such as Bioinformatics Solutions Inc., Charles River Laboratories and Agile Technologies. how. Provides quantitative analysis. Ltd. and Proteome Factory and Rapid Novor Inc. and Selvita, SGS, Shimadzu and Thermo Fisher Scientific Inc. and Waters are the key players in the global protein sequencing market for this report.
Read more Reports@
Japan Severe Keratitis Market
Japan Leber\’s Hereditary Optic Neuropathy (LHON) Market
Japan Stargardt Disease (STGD) Market
Japan Metabolic Acidosis Market
Japan Macular Edema (ME) Market
Japan Trichotillomania (TTM) Market
Japan Thyroid Eye Disease (TED) Market
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research, are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.
Name: Kenneth research
Phone: +1 313 462 0609